Who Owns Dermata Therapeutics Stock?
NASDAQ: DRMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 12:09 PM ET
Ownership breakdown
- Held by institutions
- 7.77%
- Held by insiders
- 27.35%
- Institutional holders
- 16
- Institutions 7.8%
- Insiders 27.4%
- Public and other 64.9%
Who owns Dermata Therapeutics stock?
Institutional investors own about 7.8% of Dermata Therapeutics's shares, spread across 16 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 27.35% of DRMA.
The largest institutional holders are Geode Capital Management, LLC (0.50%), Welch & Forbes, LLC (0.50%) and State Street Corporation (0.47%). Together, the top 10 institutions control 3.1% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their DRMA positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DRMA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Geode Capital Management, LLC | 20.20K | 0.50% | -58.2% |
| Welch & Forbes, LLC | 20.00K | 0.50% | 0.0% |
| State Street Corporation | 18.75K | 0.47% | +100.0% |
| UBS Group AG | 16.80K | 0.42% | -52.8% |
| Susquehanna International Group, LLP | 15.99K | 0.40% | +100.0% |
| Xtx Topco Ltd | 14.79K | 0.37% | +100.0% |
| Advisory Alpha, LLC | 10.00K | 0.25% | +100.0% |
| Tower Research Capital LLC (TRC) | 3.86K | 0.10% | +439.1% |
| MCF Advisors LLC | 1.73K | 0.04% | 0.0% |
| Barclays Plc | 270 | 0.01% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DRMA
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 19.10K | 0.47% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.11K | 0.03% |
Frequently asked questions
Who is the largest shareholder of Dermata Therapeutics?
Geode Capital Management, LLC is the largest institutional shareholder of DRMA, owning 0.50% of shares outstanding (20.20K shares) as of its latest 13F filing.
What percentage of Dermata Therapeutics is owned by institutions?
Institutions own about 7.8% of DRMA shares and 10.7% of the public float.
How much of Dermata Therapeutics do insiders own?
Insiders, such as officers and directors, own about 27.35% of DRMA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.